Publication | Open Access

Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods

Prognostic BiomarkersDisease RelapseOncologyBreast OncologyMedicineMetabolomic ProfilingPathologyMicrometastatic DiseaseBreast CancerBiostatisticsBiomarker DiscoveryMetabolomicsMolecular DiagnosticsSerum-detectable Metabolomic FingerprintCancer Research